Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Apr;9(2):255-256.
doi: 10.21037/hbsn.2019.10.17.

Incidence of hepatocellular carcinoma after HCV eradication: assessing the risk

Marcello Maida  1 , Fabio Salvatore Macaluso  2
Affiliations
Editorial

Incidence of hepatocellular carcinoma after HCV eradication: assessing the risk

Marcello Maida et al. Hepatobiliary Surg Nutr. 2020 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/hbsn.2019.10.17). The authors have no conflicts of interest to declare.

Comment on

References

    1. Maida M, Malizia G, Affronti A, et al. Screening and surveillance for hepatocellular carcinoma: perspective of a new era? Expert Rev Anticancer Ther 2016;16:1291-302. 10.1080/14737140.2016.1246965 - DOI - PubMed
    1. Singal AK, Singh A, Jaganmohan S, et al. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol 2010;8:192-9. 10.1016/j.cgh.2009.10.026 - DOI - PubMed
    1. Morgan RL, Baack B, Smith BD, et al. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies. Ann Intern Med 2013;158:329-37. 10.7326/0003-4819-158-5-201303050-00005 - DOI - PubMed
    1. Ioannou GN, Green PK, Berry K. HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma. J Hepatol 2017. [Epub ahead of print]. - PMC - PubMed
    1. Calvaruso V, Cabibbo G, Cacciola I, et al. Rete Sicilia Selezione Terapia–HCV (RESIST-HCV). Incidence of hepatocellular carcinoma in patients with HCV-associated cirrhosis treated with direct-acting antiviral agents. Gastroenterology 2018;155:411-21.e4. 10.1053/j.gastro.2018.04.008 - DOI - PubMed